BioLife Solutions
BLFS
194 hedge funds and large institutions have $1.07B invested in BioLife Solutions in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 51 reducing their positions, and 25 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 51
32% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 25
3% more funds holding
Funds holding: 188 → 194 (+6)
2.57% more ownership
Funds ownership: 102.45% → 105.02% (+2.6%)
4% less capital invested
Capital invested by funds: $1.12B → $1.07B (-$50.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less call options, than puts
Call options by funds: $6K | Put options by funds: $18K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$65.3M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$7.61M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.7M |
| 4 |
Renaissance Technologies
New York
|
+$5.84M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$22.5M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$21.6M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$10.6M |
| 4 |
Millennium Management
New York
|
-$8.15M |
| 5 |
RA
Royce & Associates
New York
|
-$7.64M |
BLFS Hedge Fund Activity: Q2 2025 in Review
194 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2025, worth a combined $1.07B — down 4.5% from $1.12B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new BLFS positions and 25 closed out — a net gain of 8 holders — while 80 added to existing stakes and 51 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $65.3M. The largest seller was Casdin Capital, cutting an estimated $22.5M.
- 194 institutional investors held BioLife Solutions (BLFS) as of Q2 2025, up from 188 in Q1 2025.
- Funds reported $1.07B of BioLife Solutions stock for Q2 2025, down 4.5% quarter-over-quarter.
- 33 funds opened new BioLife Solutions positions in Q2 2025 and 25 closed out, a net change of +8 holders.
- The largest BioLife Solutions buyer in Q2 2025 was T. Rowe Price Investment Management, an estimated $65.3M added.
- The largest BioLife Solutions seller in Q2 2025 was Casdin Capital, an estimated $22.5M sold.
Based on aggregated 13F filings for Q2 2025.